Neurology News

The FDA approved an obstructive sleep apnea neurostimulation therapy for patients aged 13 years and older with Down syndrome, according to a manufacturer-issued press release.

Ravulizumab was associated with fewer clinical deterioration events in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis, according to a poster at the 2023 MDA Clinical & Scientific Conference.

Excessive daytime sleepiness is a common symptom of several sleep disorders, including obstructive sleep apnea, which is estimated to affect 10% to 30% of adults in the U.S and often goes underdiagnosed, according to the Sleep Foundation.

Treatment with givinostat was associated with improvement in mobility and physical function compared with placebo in ambulant boys with Duchenne muscular dystrophy, according to a poster at the 2023 MDA Clinical & Scientific Conference.

NEW ORLEANS — A device designed to improve cerebral blood flow with compression of lower limbs synchronized to the cardiac cycle was tied to improved cognitive performance scores in mild cognitive impairment or Alzheimer’s disease.

The AMA and 118 other leading medical societies recently announced that they have united in support of CMS’ prior authorization reform proposal.

In a ceremony Monday at its annual meeting, the Muscular Dystrophy Association presented the 2023 Legacy Award for Achievement in Clinical Research to Merit Cudkowicz, MD, MSC, a renowned neurologist and researcher in ALS.

Results from a phase 3 clinical trial showed that Radicava ORS was safe in and well-tolerated by patients with ALS after 48 weeks of treatment, according to a manufacturer press release.

Patients with obstructive sleep apnea showed impaired emotional memory after one night of sleep, according to study results published in Annals of the American Thoracic Society.

Stoke Therapeutics Inc. announced the FDA will allow administration of a higher single dose of its investigational drug STK-001 in its ongoing phase 1/2a MONARCH study of children and adolescents with Dravet syndrome.